Multimodal kidney-preserving approach in localised and locally advanced high-risk upper tract urothelial carcinoma.

Journal: BJUI compass
Published Date:

Abstract

OBJECTIVES: Multimodal kidney-preserving (MKP) strategies may be an option for patients with localised or locally advanced high-risk upper tract urothelial carcinoma (UTUC) who have a relative contraindication for nephroureterectomy (NU).

Authors

  • Omar Alhalabi
    Department of Genitourinary Medical Oncology, Division of Cancer Medicine University of Texas MD Anderson Cancer Center Houston TX USA.
  • Matthew T Campbell
    Department of Genitourinary Medical Oncology, Division of Cancer Medicine University of Texas MD Anderson Cancer Center Houston TX USA.
  • Lianchun Xiao
    Department of Biostatistics, Division of Cancer Medicine University of Texas MD Anderson Cancer Center Houston TX USA.
  • Ana C Adriazola
    Department of Genitourinary Medical Oncology, Division of Cancer Medicine University of Texas MD Anderson Cancer Center Houston TX USA.
  • Nathaniel R Wilson
    Department of Internal Medicine University of Texas Health Science Center at Houston Houston TX USA.
  • Arlene O Siefker-Radtke
    Department of Genitourinary Medical Oncology, Division of Cancer Medicine University of Texas MD Anderson Cancer Center Houston TX USA.
  • Paul G Corn
    Department of Genitourinary Medical Oncology, Division of Cancer Medicine University of Texas MD Anderson Cancer Center Houston TX USA.
  • Amado Zurita
    Department of Genitourinary Medical Oncology, Division of Cancer Medicine University of Texas MD Anderson Cancer Center Houston TX USA.
  • Eric Jonasch
    Department of Genitourinary Medical Oncology, Division of Cancer Medicine University of Texas MD Anderson Cancer Center Houston TX USA.
  • Jianjun Gao
    Department of Genitourinary Medical Oncology, Division of Cancer Medicine University of Texas MD Anderson Cancer Center Houston TX USA.
  • Mehrad Adibi
    Department of Urology, Division of Surgery University of Texas MD Anderson Cancer Center Houston TX USA.
  • Ashish M Kamat
    Department of Urology, Division of Surgery University of Texas MD Anderson Cancer Center Houston TX USA.
  • Neema Navai
    Department of Urology, Division of Surgery University of Texas MD Anderson Cancer Center Houston TX USA.
  • Louis L Pisters
    Department of Urology, Division of Surgery University of Texas MD Anderson Cancer Center Houston TX USA.
  • Colin Dinney
    Department of Urology, Division of Surgery University of Texas MD Anderson Cancer Center Houston TX USA.
  • Surena F Matin
    Department of Urology, Division of Surgery University of Texas MD Anderson Cancer Center Houston TX USA.
  • Amishi Y Shah
    Department of Genitourinary Medical Oncology, Division of Cancer Medicine University of Texas MD Anderson Cancer Center Houston TX USA.

Keywords

No keywords available for this article.